Молекулярно-генетические маркеры радиочувствительности, позволяющие прогнозировать появление радиационных повреждений у больных, проходящих лучевую терапию

Автор: Шайхаев Е.Г.

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Статья в выпуске: 4 т.18, 2018 года.

Бесплатный доступ

Резюме Данная работа посвящена новому направлению в радиационной генетике - радиогеномике, основной целью которой является изучение молекулярно-генетических маркеров, ответственных за развитие лучевых реакций и повреждений у больных, проходящих лучевую терапию. Описаны молекулярные механизмы, активирующиеся в клетке в ответ на действие ионизирующего излучения и влияющие на развитие побочных эффектов. Представлены основные подходы, значимые на сегодняшний день результаты и проблемы радиогеномных исследований.

Лучевая терапия, лучевые реакции, генетические маркеры, радиогеномика

Короткий адрес: https://sciup.org/149132077

IDR: 149132077

Список литературы Молекулярно-генетические маркеры радиочувствительности, позволяющие прогнозировать появление радиационных повреждений у больных, проходящих лучевую терапию

Климанов В.А.радиобиологическое и дози-метрическое планирование лучевой и радионуклидной терапии. Часть 2. Лучевая терапия пучками протонов, ионов, нейтронов и пучками с модулированной интенсивностью, стереотаксис, брахитерапия, радионуклидная терапия, оптимизация, гарантия качества: учебное пособие. М.: НИЯУМИФИ, 2011. 604 с.
Andreassen C.N., Alsner J. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother Oncol. 2009. V. 92. No. 3. P. 299-309.
Barnett G.C., Thompson D., Fachal L. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. Radiother Oncol. 2014. V. 111. No. 2. P. 178-185.
Bentzen S.M., Overgaard M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol. 1991. V. 20. No. 3. P. 159-165.
Burnet N.G., Nyman J., Turesson I., et al. Improving radiotherapy cure rates by predicting normal tissue tolerance from in vitro cellular radiation sensitivity. Radiother Oncol. 1994. V. 33. P. 228-238.
Clarke G.M., Anderson C.A., Pettersson F.H., et al. Basic statistical analysis in genetic case-control studies. Nat Protoc. 2011. V. 6. No. 2. P. 121-133.
Damaraju S., Murray D., Dufour J., et al. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res. 2006. V. 12. No. 8. P. 2545-2554.
Edvardsen H., Tefre T., Jansen L., et al. Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence. Radiat Oncol. 2007.V. 2. No. 2. P. 25.
Erichsen H.C., Chanock S.J. SNPs in cancer research and treatment. Br J Cancer. 2004 V. 90. No. 4. P. 747-751.
Fachal L., Gomez-Caamano A., Barnett G.C. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nat Genet. 2014. V. 46. No. 8. P. 891-894.
Gatti R.A., Berkel I., Boder E., et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature. 1988. V. 336. No. 6199. P. 577-580.
Hayden E.C. Technology: The $1,000genome. Nature. 2014. V. 507. No. 7492. P. 294-
Jackson S.P. Sensing and repairing DNA double-strand breaks. Carcinogenesis. 2002. V. 23. No. 5. P. 687-696.
Kerns S.L., Ostrer H., Rosenstein B.S. Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discov. 2014 V. 4. No. 2. P. 155-165.
Kerns S.L., Ostrer H., Stock R. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010. V. 78. No. 5. P. 1292-1300.
Kerns S.L., Stock R., Stone N., et al. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010. V. 85. No. 1. P. e21-
Kerns S.L., Stock R.G., Stone N.N. Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. Radiother Oncol. 2013. V. 107. No. 3. P. 372-376.
Mangoni M., Bisanzi S., Carozzi F., et al. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys. 2011. V. 81. No. 1. P. 52-
Pollard J.M., Gatti R.A. Clinical radiation sensitivity with DNA repair disorders: an overview. Int J Radiat Oncol Biol Phys. 2009. V. 74. No. 5. P. 1323-1331.
Polo S.E., Jackson S.P. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev. 2011. V. 25. No. 5. P. 409-433.
Rosenstein B.S. Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity. Semin Radiat Oncol. 2017. V. 27. No. 4. P. 300-309.
Scaife J.E., Barnett G.C., Noble D.J. Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment. Br J Radiol. 2015. V. 88. No. 1051. Article ID 20150172.
Schmitz A., Bayer J., Dechamps N., et al. Heritability of susceptibility to ionizing radiation-induced apoptosis of human lymphocyte subpopulations. Int J Radiat Oncol Biol Phys. 2007. V. 68. No. 4. P. 1169-1177.
Surowy H., Rinckleb A., Luedeke M., et al. Heritability of baseline and induced micronucleus frequencies. Mutagenesis. 2011. V. 26. No. 1. P. 111-117.
Talbot C.J., Tanteles G.A., Barnett G.C. A replicated association between polymorphisms near TNF alpha and risk for adverse reactions to radiotherapy. Br J Cancer. 2012. V. 107. No. 4. P. 748-753.
West C., Rosenstein B.S. Establishment of a radiogenomics consortium. Radiother Oncol. V. 94. No. 1. P. 117-118.
West C., Rosenstein B.S., Alsner J., et al. Establishment of a Radiogenomics Consortium. Int J Radiat Oncol Biol Phys. V. 76. No. 5. P. 1295-1296.
West C.M., Barnett G.C. Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med. 2011. V. 3. No. 8. P. 52.
Zhao W., Diz D.I., Robbins M.E. Oxidative damage pathways in relation to normal tissue injury. Br J Radiol. 2007. V. 80. Spec No. 1. S23-31.

Еще

Статья научная